Patents by Inventor Stuart Holman

Stuart Holman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090312325
    Abstract: There are provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20, and R34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
    Type: Application
    Filed: May 29, 2009
    Publication date: December 17, 2009
    Inventors: Ian Robert Baldwin, Michael David Barker, Anthony William Dean, Colin David Eldred, Brian Evans, Sharon Lisa Gough, Stephen Barry Guntrip, Julie Nicole Hamblin, Stuart Holman, Paul Jones, Mika Kristian Lindvall, Christopher James Lunniss, Tracy Jane Redfern, Alison Judith Redgrave, John Edward Robinson, Michael Woodrow
  • Patent number: 7572915
    Abstract: There are provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20, and R34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
    Type: Grant
    Filed: February 8, 2006
    Date of Patent: August 11, 2009
    Assignee: Glaxo Group Limited
    Inventors: Michael David Barker, Anthony William Dean, Brian Evans, Stuart Holman, Michael Woodrow
  • Patent number: 7566786
    Abstract: There are provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20, and R34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
    Type: Grant
    Filed: May 19, 2004
    Date of Patent: July 28, 2009
    Assignee: Glaxo Group Limited
    Inventors: Ian Robert Baldwin, Michael David Barker, Anthony William Dean, Colin David Eldred, Brian Evans, Sharon Lisa Gough, Stephen Barry Guntrip, Julie Nicole Hamblin, Stuart Holman, Paul Jones, Mika Kristian Lindvall, Christopher James Lunniss, Tracy Jane Redfern, Alison Judith Redgrave, John Edward Robinson, Michael Woodrow
  • Publication number: 20090131431
    Abstract: The invention provides a compound of formula (I) or a salt thereof: wherein R2 is H, C1-3alkyl, n-butyl, C1-2fluoroalkyl, cyclopropyl, cyclobutyl, (cyclopropyl)methyl-, —CN, or —CH2OH; R3 is inter alia optionally substituted C4-7cycloalkyl or an optionally substituted heterocyclic group (aa), (bb) or (cc); Ra is H, methyl or ethyl; Rb is H or methyl; R4 is H, methyl, ethyl, n-propyl, —C(O)-Me, or —C(O)—C1fluoroalkyl; and R5 is: —C(O)—(CH2)n—Ar, —C(O)-Het, —C(O)—C1-6alkyl, —C(O)—C1 fluoroalkyl, —C(O)—(CH2)2—C(O)—NR15bNR15b, —C(O)—CH2—C(O)—NR15bNR15b, —C(O)—NR15b—(CH2)m1—Ar, —C(O)—NR15b—Het, —C(O)—NR15b—C1-6alkyl, —C(O)—NR5aR5b, —S(O)2—(CH2)m2—Ar, —S(O)2-Het, —S(O)2—C1-6alkyl, or —CH2—Ar; or R4 and R5 taken together are —(CH2)p1—, —(CH2)2—X5—(CH2)2—, —C(O)—(CH2)p2—, —C(O)—N(R15)—(CH2)p3—; or NR4R5 is of sub-formula (y), (y1), (y2) or (y3).
    Type: Application
    Filed: September 29, 2006
    Publication date: May 21, 2009
    Inventors: Christopher David Edlin, Stuart Holman, Paul Spencer Jones, Suzanne Elaine Keeling, Mika Kristian Lindvall, Charlotte Jane Mitchell, Naimisha Trivedi
  • Publication number: 20080255186
    Abstract: The invention provides N-{[1,6-diethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]methyl}-3-methyl-5-isoxazolecarboxamide or a salt thereof, such as the compound or a pharmaceutically acceptable salt thereof. The invention also provides the use of the compound or salt as an inhibitor of phosphodiesterase type IV (PDE4.
    Type: Application
    Filed: September 29, 2006
    Publication date: October 16, 2008
    Inventors: Siegfried Benjamin Christensen, Stuart Holman, Suzanne Elaine Keeling, Amyn Pyarali Sayani
  • Publication number: 20070142373
    Abstract: There are provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20, and R34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
    Type: Application
    Filed: May 19, 2004
    Publication date: June 21, 2007
    Inventors: Ian Baldwin, Michael Barker, Anthony Dean, Colin Eldred, Brian Evans, Sharon Gough, Stephen Guntrip, Julie Hamblin, Stuart Holman, Paul Jones, Mika Lindvall, Christopher Lunniss, Tracy Redfern, Alison Redgrave, John Robinson, Michael Woodrow
  • Publication number: 20060178416
    Abstract: There are provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20, and R34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
    Type: Application
    Filed: February 8, 2006
    Publication date: August 10, 2006
    Inventors: Michael Barker, Anthony Dean, Brian Evans, Stuart Holman, Michael Woodrow
  • Patent number: 6867192
    Abstract: There are provided according to the invention, novel compounds of formula (I) wherein R1, R2, R3, R4, R5 and R6 are as defined in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
    Type: Grant
    Filed: December 16, 1999
    Date of Patent: March 15, 2005
    Inventors: Duncan Robert Armour, David Brown, Miles Stuart Congreve, Paul Martin Gore, Darren Victor Steven Green, Stuart Holman, Torquil Iain Maclean Jack, Steven Philip Keeling, Andrew McMurtrie Mason, Karen Morriss, Nigel Grahame Ramsden, Peter Ward
  • Publication number: 20040044035
    Abstract: The present invention relates to a pharmaceutical formation which comprises an aqueous suspension of particulate (2S)-3-[4-({[4-aminocarbonyl)-1-piperidinyl]carbonyl}oxy)phenyl]-2-[((2S)-4-methyl-2-{[2-(2-methylphenoxy)acetyl]amino}pentanoyl)amino]propanoic acid or a salt or solvate thereof. Methods and uses of the formulation in the treatment of allergic rhinitis are also described, as are containers containing said formulation.
    Type: Application
    Filed: August 21, 2003
    Publication date: March 4, 2004
    Inventors: Duncan Robert Armour, David Brown, Miles Stuart Congreve, Paul Martin Gore, Darren Victor, Steven Green, Stuart Holman, Torquil Iain, Maclean Jack, Steven Philip Keeling, Andrew McMurtrie Mason, Karen Morriss, Nigel Grahame Ramsden, Marian Thomas, Peter Ward
  • Publication number: 20040037784
    Abstract: The present invention relates to a dry powder pharmaceutical formulation suitable for inhalation therapy comprising particulate (2S)-3-[4-({[4-(aminocarbonyl)-1-piperidinyl]carbonyl}oxy)phenyl]-2-[((2S)-4-methyl-2-{[2-(2-methylphenoxy)acetyl]amino}pentanoyl)amino] propanoic acid or a salt or solvate thereof and one or more suitable excipients. Methods and uses of the formulation in the treatment of inflammatory diseases are also described, as are medicament packs and inhalation devices containing said formulation.
    Type: Application
    Filed: August 21, 2003
    Publication date: February 26, 2004
    Inventors: Duncan Robert Armour, David Brown, Miles Stuart Congreve, Paul Martin Gore, Darren Victor Steven Green, Stuart Holman, Torquil Iain Maclean Jack, Steven Philip Keeling, Andrew McMurtrie Mason, Karen Morris, Nigel Grahame Ramsden, Marian Thomas, Peter Ward
  • Publication number: 20040039020
    Abstract: The present invention relates to a pharmaceutical formulation suitable for nebulisation which comprises an aqueous suspension of (2S)-3-[4-({[4-(aminocarbonyl)-1-piperidinyl]carbonyl}oxy)phenyl]-2-{[2-(2-methylphenoxy)acetyl]amino}pentanoyl)amino] propanoic acid or a salt or solvate thereof. Methods and uses of the formulation in the treatment of respiratory disorders such as asthma are also described.
    Type: Application
    Filed: August 15, 2003
    Publication date: February 26, 2004
    Inventors: Duncan Armour, David Brown, Miles Congreve, Paul Gore, Darren Green, Stuart Holman, Torquil Jack, Steven Keeling, Andrew Mason, Karen Morriss, Nigel Ramsden, Marian Thomas, Peter Ward
  • Publication number: 20040039021
    Abstract: The present invention relates to a pharmaceutical aerosol formulation comprising a hydrofluoroalkane (HFA) propellant having suspended therein particulate (2S)-3-[4-({[4-(aminocarbonyl)-1-piperidinyl]carbonyl}oxy)phenyl]-2-[((2S)-4-methyl-2-{[2-(2-methylphenoxy)acetyl]amino}pentanoyl)amino] propanoic acid or a salt or solvate thereof. Methods and uses of the formulation in the treatment of respiratory disorders are also described, as are canisters and metered dose inhalers containing said formulation.
    Type: Application
    Filed: August 21, 2003
    Publication date: February 26, 2004
    Inventors: Duncan Robert Armour, David Brown, Miles Congreve, Paul Gore, Darren Victor, Steven Green, Stuart Holman, Torquil Iain, Maclean Jack, Steven Philip Keeling, Andrew McMurtrie Mason, Karen Morriss, Nigel Grahame Ramsden, Marian Thomas, Peter Ward
  • Publication number: 20040034058
    Abstract: The present invention relates to a pharmaceutical formulation suitable for nebulisation which comprises an aqueous solution of (2S)-3-[4-({[4-(aminocarbonyl)-1-piperidinyl]carbonyl}oxy)phenyl]-2-[((2S)-4-methyl-2-{[2-(2-methylphenoxy)acetyl]amino}pentanoyl)amino] propanoic acid or a salt or solvate thereof. Methods and uses of the formulation in the treatment of respiratory disorders such as asthma are also described.
    Type: Application
    Filed: August 15, 2003
    Publication date: February 19, 2004
    Inventors: Duncan Armour, David Brown, Miles Congreve, Paul Gore, Darren Green, Stuart Holman, Torquil Jack, Andrew Mason, Karen Morriss, Nigel Ramsden, Marian Thomas, Peter Ward
  • Publication number: 20040034062
    Abstract: The present invention relates to a pharmaceutical formulation which comprises: an aqueous solution of (2S)-3-[4-({[4-(aminocarbonyl)-1-piperidinyl]carbonyl}oxy)phenyl]-2-[((2S)-4-methyl-2-{[2-(2-methylphenoxy)acetyl]amino}pentanoyl)amino] propanoic acid or a salt or solvate thereof. Methods and uses of the formulation in the treatment of allergic rhinitis are also described, as are containers containing said formulation.
    Type: Application
    Filed: August 21, 2003
    Publication date: February 19, 2004
    Inventors: Duncan Robert Armour, David Brown, Miles Stuart Congreve, Paul Martin Gore, Darren Victor Green, Stuart Holman, Andrew McMurtrie Mason, Karen Morris, Nigel Grahame Ramsden, Marian Thomas, Peter Ward
  • Patent number: 5576312
    Abstract: The present invention relates to compounds of formula (I) ##STR1## and salts and metabolically labile esters thereof; wherein R is a 5 or 6 membered nitrogen containing heteroaryl group, which heteroaryl group optionally contains 1 or 2 additional heteroatoms selected from nitrogen, oxygen or sulphur and said heteroaryl group is linked to the alkylene chain (CH.sub.2)n via a nitrogen atom in the heteroaryl group; n is an integer from 2 to 4, to processes for their preparation and to their use as antibacterial agents.
    Type: Grant
    Filed: February 21, 1995
    Date of Patent: November 19, 1996
    Assignee: Glaxo SpA
    Inventors: Roberto Carlesso, Stuart Holman, Alcide Perboni, Tino Rossi
  • Patent number: 4690917
    Abstract: Compounds of the formula: ##STR1## wherein R.sub.1, R.sub.3 and R.sub.4 each independently represents a hydrogen atom or a protecting group;R.sub.2 represents a halogen atom or a group of formula --NR.sub.a R.sub.b (where R.sub.a and R.sub.b, which may be the same or different, each represents a hydrogen atom or an alkyl group; or R.sub.a and R.sub.b may be linked to form, together with the nitrogen atom to which they are attached, a heterocyclic ring which optionally contains a further heteroatom);and their physiological equivalents as well as salts thereof with acids, exhibit antiviral activity against RNA viruses such as Influenza and/or are intermeidates for the preparation of antivirally active compounds.
    Type: Grant
    Filed: November 22, 1985
    Date of Patent: September 1, 1987
    Assignee: Glaxo Group Limited
    Inventors: David J. Knight, David I. C. Scopes, Richard Storer, Stuart Holman